FTN: Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT00635986
Collaborator
(none)
30
1
30

Study Details

Study Description

Brief Summary

CONTEXT AND OBJECTIVE: Controversies exist regarding the site of action of Fentanyl after epidural injection. The objective of this investigation was to compare the analgesic effect of epidural and intravenous Fentanyl for lower limb orthopedic surgeries.

DESIGN AND SETTING: A randomized and double-blind study was performed in Hospital São Paulo.

METHODS: 29 patients were divided into two groups. During the postoperative period, in the presence of pain, group 1 (n = 14) patients received 5 mL of a 100 mcg Fentanyl solution in saline without preservative by the epidural route and 2 mL saline intravenously. Group 2 (n = 15) patients received 5 mL saline by the epidural route and 2 mL (100 mcg) Fentanyl intravenously. Analgesic supplementation consisted of 40 mg intravenous Tenoxicam and 5 mL epidural 0.25% bupivacaine (if pain relief was not achieved with Tenoxicam). Pain intensity was evaluated by numerical scale and plasma concentrations of Fentanyl were measured simultaneously.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl
Study Start Date :
May 1, 2004
Actual Primary Completion Date :
Jun 1, 2005
Actual Study Completion Date :
Nov 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

group 1 (n = 14) patients received 5 mL of a 100 mcg Fentanyl solution in saline without preservative by the epidural route and 2 mL saline intravenously. Group 2 (n = 15) patients received 5 mL saline by the epidural route and 2 mL (100 mcg) Fentanyl intravenously

Drug: Fentanyl
100 mcg Fentanyl intravenous or epidural route

Outcome Measures

Primary Outcome Measures

  1. Pain relief [1 year]

Secondary Outcome Measures

  1. fentanyl plasma concentration measure in different times [1year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Both genders ranging in age from 18 to 65 years, American Society of Anesthesiologists (ASA) Physical Status 1 or 2, scheduled for orthopedic bone surgery of the lower limbs
Exclusion Criteria:
  • Patients with infection in the puncture area and coagulation disorders, pregnant patients, and patients using opioids

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Federal University of São Paulo

Investigators

  • Study Chair: Adriana M Issy, PhD, Federal University of São Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00635986
Other Study ID Numbers:
  • Fentanyl
  • No grant
First Posted:
Mar 14, 2008
Last Update Posted:
Mar 14, 2008
Last Verified:
Mar 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2008